---
category: news
title: "Amid Roche and Sanofi's oral SERD set足backs, Menar足i足ni gets speedy re足view at FDA"
excerpt: "Menarini and Radius Health are getting a speedy review at the FDA for their oral SERD breast cancer drug months after the field opened up with competitors failing and fleeing. It was a one-two-three punch in March,"
publishedDateTime: 2022-08-11T13:32:00Z
originalUrl: "https://endpts.com/amid-roche-and-sanofis-oral-serd-setbacks-menarini-gets-speedy-review-at-fda/"
webUrl: "https://endpts.com/amid-roche-and-sanofis-oral-serd-setbacks-menarini-gets-speedy-review-at-fda/"
type: article
quality: 0
heat: 0
published: false

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - Computer Vision
  - AI

secured: "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;HO1P6J5D0u5kyBnZpNQ2Aw=="
---

